Scintica and Trust Bio-sonics announce exclusive partnership for the distribution of its preclinical USphereâ„¢ Series Contrast Agents [January 27, 2022] Scintica is excited to announce its exclusive distribution agreement for North America and Europe with Trust Bio-sonics, a pharmaceutical company and developer of the USphere Series of contrast agents for translational research and medicine
Scintica and Especialidades Médicas Myr, S.L. announce exclusive partnership for the distribution of its Electromedical Instruments for Anatomical Pathology [January 24, 2022] Scintica is excited to announce its exclusive distribution agreement for Canada with Especialidades Médicas Myr, S.L., developer, and manufacturer of electromedical instruments for anatomical pathology. Myr has over 30 years of experience
[January 5, 2022] Scintica is excited to announce its new and extended distribution agreement for preclinical products with Aspect Imaging, global leader in innovative, high-performance permanent magnet MRI technology. Aspect imaging has been pushing the boundaries of permanent magnet design to deliver easy-to-use MR imaging solutions for both clinical and preclinical market segments. The
Poietis and Assistance Publique - Hôpitaux de Marseille (AP-HM) announce the first installation of a 3D bioprinting platform for manufacturing implantable biological tissues in hospitals The
[July 26, 2021] Scintica is excited to announce its new and extended distribution agreement with Baker Ruskinn, global leader and supplier of anaerobic and modified atmosphere solutions for microbiology and tissue/cell culture applications. The Baker Company, global leader in containment technology, owner of Baker Ruskinn, itself a global leader in anaerobic and precision low-oxygen
